Table 6.
Authors, Year | EUS | MRI | CT | SRS | 68Ga-PET/CT |
---|---|---|---|---|---|
Albers et al., 2017 [33] | |||||
n | 27 | 27 | 27 | ||
Sensitivity, % | 100 | 74 | 78 | ||
Barbe et al., 2012a [32] | |||||
n | 75 | 67 | |||
Sensitivity, % | 83 | 74 | |||
Lastoria et al., 2016 [45] | |||||
n | 11 | ||||
Sensitivity, % | 100 | ||||
van Asselt et al., 2015a,b,c [36] | |||||
n | 35 | 35 | |||
Sensitivity, % | 97 | 51 | |||
Morgat et al., 2016c [35] | |||||
n | 76 | 76 | 76 | ||
Sensitivity, % | 60 | 20 | 76 | ||
Specificity, % | 50 | 50 | 100 | ||
Gauger et al., 2003 [43] | |||||
n | 13 | ||||
Sensitivity, % | 92 | ||||
Hellman et al., 2005d [44] | |||||
n | 22/8 | ||||
Sensitivity, % | 64/50 | ||||
Goroshi et al., 2016c [39] | |||||
n | 13 | 13 | |||
Sensitivity, % | 63 | 100 | |||
Wamsteker et al., 2003c [42] | |||||
n | 10 | ||||
Sensitivity, % | 82 | ||||
Langer et al., 2004 [34] | |||||
n | 16 | 13 | 17 | ||
Sensitivity, % | 75 | 54 | 71 | ||
Lewis et al., 2012 [28] | |||||
n | 35 | 8 | 43 | 32 | |
Sensitivity, % | 100 | 88 | 81 | 84 | – |
Camera et al., 2011c [40] | |||||
n | 11 | ||||
Sensitivity, % | 78 | ||||
Skogseid et al., 1998e [41] | |||||
n | 15/10 | 15/10 | |||
Sensitivity, % | 57/20 | 75/0 | |||
Waldmann et al., 2009 [37] | |||||
n | 20 | 24 | 24 | ||
Sensitivity, % | 100 | 62 | 54 | ||
Yim et al., 1998c [38] | |||||
n | 16 | ||||
Sensitivity, % | 58 |
Abbreviation: n, number of included patients in the study.
Results from analysis for pNETs > 1 cm.
Not every patient received an MRI or CT (either MRI or CT), so sensitivity could not be extracted.
Sensitivity based on per-lesion analysis in n patients.
No reference standard was described for the index test. Results in table are distracted from the article with biochemical signs (n = 22)/histopathology (n = 8) as reference standard.
Population and sensitivity for major disease/limited disease.